{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T12:46:14Z","timestamp":1770986774258,"version":"3.50.1"},"reference-count":124,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2001,6,1]],"date-time":"2001-06-01T00:00:00Z","timestamp":991353600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2001,6]]},"DOI":"10.1016\/s1040-8428(01)00103-2","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T17:14:12Z","timestamp":1027617252000},"page":"177-192","source":"Crossref","is-referenced-by-count":84,"title":["Delivery systems intended for in vivo gene therapy of cancer: targeting and replication competent viral vectors"],"prefix":"10.1016","volume":"38","author":[{"given":"Evanthia","family":"Galanis","sequence":"first","affiliation":[]},{"given":"Richard","family":"Vile","sequence":"additional","affiliation":[]},{"given":"Stephen J","family":"Russell","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S1040-8428(01)00103-2_BIB1","first-page":"585","article-title":"Molecular mechanisms of oncogenesis","volume":"60","author":"Seemayer","year":"1989","journal-title":"Lab. Invest."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB2","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/0140-6736(92)90606-4","article-title":"Gene therapy for cancer","volume":"339","author":"Gutierrez","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/S1040-8428(01)00103-2_BIB3","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0167-7799(93)90114-O","article-title":"Gene therapy for cancer","volume":"11","author":"Sokora","year":"1993","journal-title":"Trends Biotechnol."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB4","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1126\/science.1589762","article-title":"Human gene therapy","volume":"256","author":"Anderson","year":"1992","journal-title":"Science"},{"key":"10.1016\/S1040-8428(01)00103-2_BIB5","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/jnci\/89.1.21","article-title":"Gene therapy for cancer: what have we done and where are we going?","volume":"89","author":"Roth","year":"1997","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB6","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF00204747","article-title":"Development of retroviral vectors as safe, targeted gene delivery systems","volume":"74","author":"Gunzburg","year":"1996","journal-title":"J. Mol. Med."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB7","series-title":"The retroviridae","first-page":"1","article-title":"Cellular receptors and viral glycoproteins involved in retrovirus entry","author":"Weiss","year":"1993"},{"key":"10.1016\/S1040-8428(01)00103-2_BIB8","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/0092-8674(95)90024-1","article-title":"Retrovirus receptors","volume":"82","author":"Weiss","year":"1995","journal-title":"Cell"},{"key":"10.1016\/S1040-8428(01)00103-2_BIB9","doi-asserted-by":"crossref","first-page":"8033","DOI":"10.1073\/pnas.90.17.8033","article-title":"Vesicular stomatitis virus G-glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells","volume":"90","author":"Burns","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S1040-8428(01)00103-2_BIB10","doi-asserted-by":"crossref","first-page":"15266","DOI":"10.1073\/pnas.93.26.15266","article-title":"Transduction of nondividing cells using pseudotyped defective high-titer HIV type 1 particles","volume":"93","author":"Reiser","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S1040-8428(01)00103-2_BIB11","unstructured":"Case SS, Price MA, Xu D, Bauer G, Naldini L, Verma IM, et al. Stable transduction of CD34+\/CD38 cells in extended long term culture using a lentiviral vector. Proc Am Soc Gene Ther 1998;104a."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB12","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1126\/science.7973726","article-title":"Tissue specific targeting of retroviral vectors through ligand-receptor interactions","volume":"266","author":"Kasahara","year":"1994","journal-title":"Science"},{"key":"10.1016\/S1040-8428(01)00103-2_BIB13","doi-asserted-by":"crossref","first-page":"9747","DOI":"10.1073\/pnas.92.21.9747","article-title":"Ligand-directed retroviral targeting of human breast cancer cells","volume":"92","author":"Han","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S1040-8428(01)00103-2_BIB14","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1099\/0022-1317-76-12-3165","article-title":"Targeted infection of a retrovirus bearing a CD4-Env chimera into human cells expressing human immunodeficiency virus type 1","volume":"76","author":"Matano","year":"1995","journal-title":"J. Gen. Virol."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB15","doi-asserted-by":"crossref","first-page":"6314","DOI":"10.1128\/JVI.69.10.6314-6322.1995","article-title":"Retroviral retargeting by envelopes expressing an N-terminal binding domain","volume":"69","author":"Cosset","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB16","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S1357-4310(97)01095-2","article-title":"Towards efficient cell targeting by recombinant retroviruses","volume":"3","author":"Marin","year":"1997","journal-title":"Mol. Med. Today"},{"key":"10.1016\/S1040-8428(01)00103-2_BIB17","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1093\/nar\/21.5.1081","article-title":"Retroviral vectors displaying functional antibody fragments","volume":"21","author":"Russell","year":"1993","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB18","doi-asserted-by":"crossref","first-page":"7570","DOI":"10.1073\/pnas.92.16.7570","article-title":"Generation of targeted retroviral vectors by using single-chain variable fragment: an approach to in vivo gene delivery","volume":"92","author":"Somia","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S1040-8428(01)00103-2_BIB19","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1128\/JVI.70.5.2957-2962.1996","article-title":"Targeted infection of human cells via major histocompatibility complex class I molecules by Moloney murine leukemia virus-derived viruses displaying single-chain antibody fragment envelope fusion proteins","volume":"70","author":"Marin","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB20","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1089\/hum.1996.7.17-2157","article-title":"Retroviral display of antibody fragments; interdomain spacing strongly influences vector infectivity","volume":"7","author":"Ager","year":"1996","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB21","first-page":"334","article-title":"Expression of chimeric envelope proteins in helper cell lines and integration into Moloney murine leukemia virus particles","volume":"3","author":"Schnierle","year":"1996","journal-title":"Gene Ther."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB22","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.1128\/JVI.68.7.4609-4619.1994","article-title":"Modifications in the binding domain of avian retrovirus envelope protein to redirect the host range of retroviral vectors","volume":"68","author":"Valsesia","year":"1994","journal-title":"J. Virol."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB23","first-page":"280","article-title":"Targeting of retroviral vectors through protease-substrate interactions","volume":"3","author":"Nilson","year":"1996","journal-title":"Gene Ther."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB24","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1089\/hum.1997.8.6-729","article-title":"A gene delivery system activatable by disease-associated matrix metalloproteinases","volume":"8","author":"Peng","year":"1997","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB25","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1038\/sj.gt.3300982","article-title":"Selective transduction of protease-rich tumors by matrix-metalloproteinase-targeted retroviral vectors","volume":"6","author":"Peng","year":"1999","journal-title":"Gene Ther."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB26","doi-asserted-by":"crossref","first-page":"10148","DOI":"10.1128\/JVI.72.12.10148-10156.1998","article-title":"Cell-type-specific gene transfer into human cells with retroviral vectors that display single-chain antibodies","volume":"72","author":"Jiang","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB27","doi-asserted-by":"crossref","unstructured":"Roux P, Jeanteur P, Piechaczyk M. Cell targeting by recombinant retrovirus using bi-specific antibody complexes. In: NATO Advanced Study Institute Series: subseries \u201cCell biology,\u201d \u201cVectors as tools for the study of normal and abnormal growth and differentiation,\u201d Berlin: Springer, 1989, p. 153\u201364.","DOI":"10.1007\/978-3-642-74197-5_14"},{"key":"10.1016\/S1040-8428(01)00103-2_BIB28","doi-asserted-by":"crossref","first-page":"9079","DOI":"10.1073\/pnas.86.23.9079","article-title":"A versatile and potentially general approach to the targeting of specific cells by retroviruses: application to the infection of human cells by means of major histocompatibility complex class I and class II antigens by mouse ecotropic murine leukemia virus-derived viruses","volume":"86","author":"Roux","year":"1989","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S1040-8428(01)00103-2_BIB29","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1099\/0022-1317-73-12-3251","article-title":"The efficiency of cell targeting by recombinant retroviruses depends on the nature of the receptor and the composition of the artificial cell-virus linker","volume":"73","author":"Etienne-Julan","year":"1992","journal-title":"J. Gen. Virol."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB30","doi-asserted-by":"crossref","first-page":"7063","DOI":"10.1073\/pnas.95.12.7063","article-title":"Cell-specific viral targeting mediated by a soluble retroviral receptor-ligand fusion protein","volume":"95","author":"Snitkovsky","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S1040-8428(01)00103-2_BIB31","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0378-1119(97)00571-4","article-title":"Molecular biology of cell nonpermissiveness to retroviruses. Has the time come?","volume":"206","author":"Svoboda","year":"1998","journal-title":"Gene"},{"key":"10.1016\/S1040-8428(01)00103-2_BIB32","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/nbt1098-951","article-title":"In vivo selection of protease cleavage sites from retrovirus display libraries","volume":"16","author":"Bucholz","year":"1998","journal-title":"Nature Biotechnol."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB33","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1128\/JVI.2.10.1064-1075.1968","article-title":"Virus-receptor interaction in an adenovirus system","volume":"2","author":"Philipson","year":"1968","journal-title":"J. Virol."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB34","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0092-8674(93)90231-E","article-title":"Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment","volume":"73","author":"Wickham","year":"1993","journal-title":"Cell"},{"key":"10.1016\/S1040-8428(01)00103-2_BIB35","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.1128\/JVI.68.6.4104-4106.1994","article-title":"Cell-binding domain of adenovirus serotype 2 fibr","volume":"68","author":"Louis","year":"1994","journal-title":"J. Virol."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB36","doi-asserted-by":"crossref","first-page":"5239","DOI":"10.1128\/JVI.68.8.5239-5246.1994","article-title":"Characterization of the knob domain of the adenovirus type 5 fiber protein expressed in Escherichia coli","volume":"68","author":"Henry","year":"1994","journal-title":"J. Virol."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB37","doi-asserted-by":"crossref","first-page":"6061","DOI":"10.1128\/JVI.65.11.6061-6070.1991","article-title":"Infectious entry pathway of adenovirus type 2","volume":"65","author":"Varga","year":"1991","journal-title":"J. Virol."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB38","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/0092-8674(93)90382-Z","article-title":"Stepwise dismantling of adenovirus 2 during entry into cells","volume":"75","author":"Greber","year":"1993","journal-title":"Cell"},{"key":"10.1016\/S1040-8428(01)00103-2_BIB39","first-page":"3396","article-title":"Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues","volume":"52","author":"Weitman","year":"1992","journal-title":"Cancer Res."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB40","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1038\/nbt1196-1574","article-title":"Targeted gene delivery by tropism-modified adenoviral vectors","volume":"14","author":"Douglas","year":"1996","journal-title":"Nature Biotechnol."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB41","first-page":"239","article-title":"The fibroblast growth factor family","volume":"3","author":"Baird","year":"1991","journal-title":"Cancer Cells"},{"key":"10.1016\/S1040-8428(01)00103-2_BIB42","first-page":"341","article-title":"Targeted adenoviral vectors for cancer gene therapy","volume":"11","author":"Douglas","year":"1997","journal-title":"Intl. J. Oncol."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB43","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1002\/1097-0142(19931001)72:7<2253::AID-CNCR2820720732>3.0.CO;2-4","article-title":"Expression of fibroblast growth factors and their receptors in acquired immunodeficiency syndrome-associated Kaposi sarcoma tissue and derived cells","volume":"72","author":"Li","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/S1040-8428(01)00103-2_BIB44","first-page":"2455","article-title":"Basic fibroblast growth factor enhancement of adenovirus-mediated delivery of the herpes simplex virus thymidine kinase gene results in augmented therapeutic benefit in a murine model of ovarian cancer","volume":"4","author":"Rancourt","year":"1998","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB45","first-page":"5738","article-title":"Differential susceptibility of primary and established human gliomas cells to adenovirus infection: targeting via receptor-independent gene transfer","volume":"58","author":"Miller","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB46","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/sj.gt.3300511","article-title":"The \u2018adenobody\u2019 approach to viral targeting: specific and enhanced adenoviral gene delivery","volume":"4","author":"Watkins","year":"1997","journal-title":"Gene Ther."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB47","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1038\/nbt1196-1570","article-title":"Adenovirus targeted to heparan-containing receptors increases its gene delivery efficiency to multiple cell types","volume":"14","author":"Wickham","year":"1996","journal-title":"Nature Biotechnol."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB48","doi-asserted-by":"crossref","first-page":"7071","DOI":"10.1128\/JVI.70.10.7071-7078.1996","article-title":"Domains required for assembly of adenovirus type 2 fiber trimers","volume":"70","author":"Hong","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB49","doi-asserted-by":"crossref","first-page":"9706","DOI":"10.1128\/JVI.72.12.9706-9713.1998","article-title":"An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism","volume":"72","author":"Dmitriev","year":"1998","journal-title":"J Virol"},{"key":"10.1016\/S1040-8428(01)00103-2_BIB50","doi-asserted-by":"crossref","first-page":"6831","DOI":"10.1128\/JVI.70.10.6831-6838.1996","article-title":"Targeted adenovirus gene transfer to endothelial and smooth muscle cells by using bispecific antibodies","volume":"70","author":"Wickham","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB51","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/978-1-4615-5357-1_57","article-title":"Targeted adenoviral vectors for cancer gene therapy","volume":"451","author":"Bilbao","year":"1998","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB52","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nm0396-299","article-title":"Toward cell-targeting gene therapy vectors: selection of cell-binding peptides from random peptide-presenting phase libraries","volume":"2","author":"Barry","year":"1996","journal-title":"Nature Med."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB53","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/380364a0","article-title":"Organ targeting in vivo using phase display peptide libraries","volume":"380","author":"Pasqualini","year":"1996","journal-title":"Nature"},{"key":"10.1016\/S1040-8428(01)00103-2_BIB54","doi-asserted-by":"crossref","unstructured":"Pieroni L, Fipaldini C, Monciotti A, Cimini D, Sgura A, et al. Targeted integration of adeno-associated virus derived plasmids in transfected human cells Virology 1998;249(9):249\u201359.","DOI":"10.1006\/viro.1998.9332"},{"key":"10.1016\/S1040-8428(01)00103-2_BIB55","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1089\/hum.1998.9.13-1929","article-title":"Development of novel cell surface CD34-targeted recombinant adeno-associated virus vectors for gene therapy","volume":"9","author":"Yang","year":"1998","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB56","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/6185","article-title":"Targeted adeno-associated virus vector transduction of nonpermissive cells mediated by a bispecific F(ab\u2032gamma) 2 antibody","volume":"17","author":"Bartlett","year":"1999","journal-title":"Nature Biotechnol."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB57","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/nbt0897-763","article-title":"Cell specific targeting of Sindbis virus vectors displaying IgG-binding domains of protein A","volume":"15","author":"Ohno","year":"1997","journal-title":"Nature Biotechnol."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB58","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/(SICI)1097-0215(19990105)80:1<110::AID-IJC21>3.0.CO;2-8","article-title":"Cell specific targeting of a thymidine kinase\/ganciclovir gene therapy system using a recombinant Sindbis virus vector","volume":"80","author":"Iijima","year":"1999","journal-title":"Intl. J. Cancer"},{"key":"10.1016\/S1040-8428(01)00103-2_BIB59","doi-asserted-by":"crossref","first-page":"9683","DOI":"10.1128\/JVI.72.12.9683-9697.1998","article-title":"Recombinant herpes simplex virus type 1 engineered for targeted binding to erythropoietin receptor-bearing cells","volume":"72","author":"Laquerre","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB60","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/315115a0","article-title":"Heritable formation of pancreatic \u03b2-cell tumours in transgenic mice expressing recombinant insulin\/simian virus 40 oncogenes","volume":"315","author":"Hanahan","year":"1985","journal-title":"Nature"},{"key":"10.1016\/S1040-8428(01)00103-2_BIB61","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1128\/MCB.12.3.905","article-title":"High-level expression of the rat whey acidic protein gene is mediated by elements in the promoter and 3\u2032 untranslated region","volume":"12","author":"Dale","year":"1992","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB62","first-page":"962","article-title":"In vitro and in vivo targeting of gene expression to melanoma cells","volume":"53","author":"Vile","year":"1993","journal-title":"Cancer Res."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB63","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1523\/JNEUROSCI.14-03-01030.1994","article-title":"GFAP promoter directs astrocyte specific expression in transgenic mice","volume":"14","author":"Brenner","year":"1994","journal-title":"J. Neurosci."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB64","doi-asserted-by":"crossref","first-page":"8039","DOI":"10.1073\/pnas.88.18.8039","article-title":"Retroviral-mediated gene therapy for the treatment of hepatocellular carcinoma: an innovative approach for cancer therapy","volume":"88","author":"Huber","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S1040-8428(01)00103-2_BIB65","doi-asserted-by":"crossref","first-page":"3791","DOI":"10.1128\/MCB.6.11.3791","article-title":"Cellular promoters incorporated into the adenovirus genome: cell specificity of albumin and immunoglobulin expression","volume":"6","author":"Friedman","year":"1986","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB66","first-page":"5258","article-title":"Gene therapy for carcinoembryonic antigen-producing human lung cancer cells by cell type-specific expression of herpes simplex virus thymidine kinase gene","volume":"54","author":"Osaki","year":"1994","journal-title":"Cancer Res."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB67","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/j.1460-2075.1988.tb02871.x","article-title":"Transcription of T-cell receptor \u03b2-chain genes is controlled by a downstream regulatory element","volume":"7","author":"Krimpenfort","year":"1988","journal-title":"EMBO J."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB68","doi-asserted-by":"crossref","first-page":"6459","DOI":"10.1021\/bi00076a020","article-title":"Androgen induction of a human prostate-specific kallikrein, hKLK2: characterization of an androgen response element in the 5\u2032 promoter region of the gene","volume":"32","author":"Murtha","year":"1993","journal-title":"Biochemistry"},{"key":"10.1016\/S1040-8428(01)00103-2_BIB69","first-page":"46","article-title":"Strategy for achieving selective killing of carcinomas","volume":"1","author":"Garver","year":"1994","journal-title":"Gene Ther."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB70","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1002\/j.1460-2075.1993.tb05891.x","article-title":"A novel transcription of factor, OB2-1, is required for overexpression of the oncogene c-erb-w in mammary tumor lines","volume":"12","author":"Hollywood","year":"1993","journal-title":"Embo J."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB71","first-page":"681","article-title":"Gene therapy for cancer using tumour-specific prodrug activation","volume":"2","author":"Harris","year":"1995","journal-title":"Gene Ther."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB72","first-page":"681","article-title":"Gene therapy for small cell lung cancer cells overexpressing myc family oncogenes by tumor-specific expression of the herpes simplex virus thymidine kinase gene","volume":"2","author":"Kumagai","year":"1995","journal-title":"Gene Ther."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB73","doi-asserted-by":"crossref","first-page":"18061","DOI":"10.1074\/jbc.271.30.18061","article-title":"Potential for H-DNA in the human MUC1 mucin gene promoter","volume":"271","author":"Nelson","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB74","first-page":"4614","article-title":"Osteocalcin promoter-based toxic gene therapy for the treatment of osteosarcoma in experimental models","volume":"56","author":"Ko","year":"1996","journal-title":"Cancer Res."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB75","first-page":"200","article-title":"Transactivation of the metallothionein promoter in cisplatin (CP) resistant cell lines: potential application for a specific gene therapy","volume":"36","author":"Rixe","year":"1995","journal-title":"Proc. Am. Assoc. Cancer Res."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB76","first-page":"4266","article-title":"Gene therapy targeted by radiation preferentially radiosensitizes tumor cells","volume":"54","author":"Weichselbaum","year":"1994","journal-title":"Cancer Res."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB77","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nm0895-786","article-title":"Spatial and temporal control of gene therapy using ionizing radiation","volume":"1","author":"Hallahan","year":"1995","journal-title":"Nature Med."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB78","first-page":"4311","article-title":"Tumour necrosis factors alpha (TNF-alpha) gene therapy targeted by ionizing radiation selectively damages the tumour vasculature","volume":"56","author":"Mauceri","year":"1996","journal-title":"Cancer Res."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB79","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/nm0597-515","article-title":"Targeting gene expression to hypoxic tumour cells","volume":"3","author":"Dachs","year":"1997","journal-title":"Nature Med."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB80","first-page":"4906","article-title":"Application of the Cre recombinase\/loxP system further enhances antitumor effects in cell type-specific gene therapy against carcinoembryonic antigen-producing cancer","volume":"59","author":"Kijima","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB81","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/0959-8049(94)90477-4","article-title":"Replicating vectors for gene therapy of cancer: risks, limitations and prospects","volume":"30A","author":"Russell","year":"1994","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/S1040-8428(01)00103-2_BIB82","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0065-3527(08)60867-2","article-title":"Emergency, natural history, and variation of canine, mink and feline parvoviruses","volume":"38","author":"Parrish","year":"1990","journal-title":"Adv. Virus Res."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB83","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1002\/1097-0142(197412)34:6<1907::AID-CNCR2820340609>3.0.CO;2-4","article-title":"Treatment of human cancer with mumps virus","volume":"34","author":"Asada","year":"1974","journal-title":"Cancer"},{"key":"10.1016\/S1040-8428(01)00103-2_BIB84","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/1097-0142(195611\/12)9:6<1211::AID-CNCR2820090624>3.0.CO;2-7","article-title":"Studies on the use of viruses in the treatment of carcinoma of the cervix","volume":"9","author":"Smith","year":"1956","journal-title":"Cancer"},{"key":"10.1016\/S1040-8428(01)00103-2_BIB85","series-title":"Virology","first-page":"1679","article-title":"Adenoviridae and their replication","author":"Horwitz","year":"1990"},{"key":"10.1016\/S1040-8428(01)00103-2_BIB86","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1126\/science.274.5286.373","article-title":"An adenovirus mutant that replicates selectively in p53-deficient human tumor cells","volume":"274","author":"Bischoff","year":"1996","journal-title":"Science"},{"key":"10.1016\/S1040-8428(01)00103-2_BIB87","doi-asserted-by":"crossref","first-page":"9470","DOI":"10.1128\/JVI.72.12.9470-9478.1998","article-title":"Replication of ONYX-015, a potential anticancer adenovirus, is independent of p53 status in tumor cells","volume":"72","author":"Rothman","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB88","doi-asserted-by":"crossref","first-page":"9479","DOI":"10.1128\/JVI.72.12.9479-9490.1998","article-title":"p53 status does not determine outcome of E1B 55-Kilodalton mutant adenovirus lytic infection","volume":"72","author":"Goodrum","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB89","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nm0697-639","article-title":"ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents","volume":"3","author":"Heise","year":"1997","journal-title":"Nature Med."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB90","first-page":"S13","article-title":"Preclinical studies with ONYX-015 (a replication competent E1B-deleted adenovirus) in combination with chemotherapy","volume":"4","author":"Heise","year":"1997","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB91","first-page":"S26","article-title":"Phase II trials of intratumoral ONYX-015, an E1B 55-kDa gene-deleted adenovirus, alone and in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer","volume":"5","author":"Nemunaitis","year":"1998","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB92","first-page":"211a","article-title":"A phase I trial of intratumoral injection with an E1B-attenuated adenovirus, ONYX-015, into unresectable carcinomas of the exocrine pancreas","volume":"17","author":"Mulvihill","year":"1998","journal-title":"Proc. Am. Soc. Clin. Oncol."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB93","first-page":"211a","article-title":"Intratumoral injection of ONYX-015 for gastrointestinal tumors metastatic to the liver: a phase I trial","volume":"17","author":"Bergsland","year":"1998","journal-title":"Proc. Am. Soc. Clin. Oncol."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB94","first-page":"382a","article-title":"Phase I trial of intraperitoneal onyx-015 adenovirus in patients with recurrent ovarian cancer","volume":"19","author":"Vasey","year":"2000","journal-title":"Proc. ASCO"},{"issue":"8","key":"10.1016\/S1040-8428(01)00103-2_BIB95","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/78638","article-title":"A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer","volume":"6","author":"Khuri","year":"2000","journal-title":"Nature Med."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB96","first-page":"2559","article-title":"Prostate attenuated replication competent adenovirus (ARCA) CN706: a selective cytotoxic for prostate-specific antigen-positive prostate cancer cells","volume":"57","author":"Rodriguez","year":"1997","journal-title":"Cancer Res."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB97","series-title":"Fields virology","first-page":"2297","article-title":"Herpes simplex viruses","author":"Whitley","year":"1996"},{"key":"10.1016\/S1040-8428(01)00103-2_BIB98","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S1357-4310(97)01106-4","article-title":"The use of herpes simplex virus-based vectors for gene delivery to the nervous system","volume":"3","author":"Lachmann","year":"1997","journal-title":"Mol. Med. Today"},{"key":"10.1016\/S1040-8428(01)00103-2_BIB99","series-title":"Fields virology","first-page":"2231","article-title":"Herpes simplex viruses and their replication","author":"Roizmann","year":"1996"},{"key":"10.1016\/S1040-8428(01)00103-2_BIB100","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1126\/science.1851332","article-title":"Experimental therapy of human glioma by means of a genetically engineered virus mutant","volume":"252","author":"Martuza","year":"1991","journal-title":"Science"},{"key":"10.1016\/S1040-8428(01)00103-2_BIB101","doi-asserted-by":"crossref","first-page":"4736","DOI":"10.1073\/pnas.86.12.4736","article-title":"Thymidine kinase-negative herpes simplex virus mutants establish latency in mouse trigeminal ganglia but do not reactivate","volume":"86","author":"Coen","year":"1989","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S1040-8428(01)00103-2_BIB102","first-page":"3963","article-title":"Tratment of malignant gliomas using ganciclovir-hypersensitive, ribonucleotide reductase-deficient herpes simplex viral mutant","volume":"56","author":"Mineta","year":"1994","journal-title":"Cancer Res."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB103","first-page":"323","article-title":"Antitumor activity and reporter gene transfer into rat brain endoplasms inoculated with herpes simplex virus vectors defective in thymidine kinase or ribonucleotide reductase","volume":"1","author":"Boviatsis","year":"1994","journal-title":"Gene Ther."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB104","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1126\/science.2173860","article-title":"Mapping of herpes simplex virus-1 neurovirulence to gamma 34.5, a gene nonessential for growth in culture","volume":"250","author":"Chou","year":"1990","journal-title":"Science"},{"key":"10.1016\/S1040-8428(01)00103-2_BIB105","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/nm0995-938","article-title":"Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas","volume":"1","author":"Mineta","year":"1995","journal-title":"Nature Med."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB106","first-page":"4752","article-title":"Treatment of human malignant meningiomas by G207, a replication-competent multimutated herpes simplex virus 1","volume":"55","author":"Yazaki","year":"1995","journal-title":"Cancer Res."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB107","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/sj.gt.3301205","article-title":"Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial","volume":"7","author":"Markert","year":"2000","journal-title":"Gene Ther."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB108","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/sj.gt.3300550","article-title":"Treatment of intracranial gliomas in immunocompetent mice using herpes simplex viruses that express murine interleukins","volume":"5","author":"Andreansky","year":"1998","journal-title":"Gene Ther."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB109","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/nbt0598-444","article-title":"An oncolytic viral mutant that delivers the CYP2B1 transgene and augments cyclophosphamide chemotherapy","volume":"16","author":"Chase","year":"1998","journal-title":"Nature Biotechnol."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB110","doi-asserted-by":"crossref","first-page":"5124","DOI":"10.1128\/JVI.71.7.5124-5132.1997","article-title":"Trascriptional targeting of herpes simplex virus for cell-specific replication","volume":"71","author":"Miyatake","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB111","first-page":"1485","article-title":"Induction of lytic Epstein-Barr virus (EBV) infection in EBV-associated malignancies using adenovirus vectors in vitro and in vivo","volume":"59","author":"Westphal","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB112","first-page":"4682","article-title":"Ras oncogenes in human cancer: a review","volume":"49","author":"Bos","year":"1989","journal-title":"Cancer Res."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB113","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1093\/emboj\/17.12.3351","article-title":"The molecular basis of viral oncolysis: usurpation of the ras signaling pathway by reovirus","volume":"17","author":"Strong","year":"1998","journal-title":"EMBO J."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB114","series-title":"Fields virology","first-page":"1597","author":"Tyler","year":"1996"},{"key":"10.1016\/S1040-8428(01)00103-2_BIB115","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1126\/science.282.5392.1332","article-title":"Reovirus therapy of tumors with activated Ras pathway","volume":"282","author":"Coffey","year":"1998","journal-title":"Science"},{"key":"10.1016\/S1040-8428(01)00103-2_BIB116","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/978-1-4615-5357-1_41","article-title":"Modification of cancer vaccines by virus infection and attachment of bispecific antibodies. An effective alternative to somatic gene therapy","volume":"451","author":"Schirrmacher","year":"1998","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB117","first-page":"677","article-title":"Immunization with virus-modified tumor cells","volume":"25","author":"Schirrmacher","year":"1998","journal-title":"Semin. Oncol."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB118","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/sj.cgt.7700048","article-title":"An effective strategy of human tumor vaccine modification by coupling bispecific costimulatory molecules","volume":"6","author":"Haas","year":"1999","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB119","unstructured":"Schirrmacher V. Newcastle Disease virus in tumor therapy. Program booklet from \u201ccytoreductive gene therapy\u201d: Harold W. Siebens Conference, September 25\u201327, 1999, Rochester, MN."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB120","first-page":"246a","article-title":"Hepatic artery infusion of Onyx-015, a selectively-replicating adenovirus, in combination with 5-FU\/leucovorin for gastrointestinal carcinoma metastatic to the liver: a phase I\/II trial","volume":"19","author":"Reid","year":"2000","journal-title":"ASCO Proc."},{"issue":"5","key":"10.1016\/S1040-8428(01)00103-2_BIB121","first-page":"S144","article-title":"Molecular and clinical activity of CN706, a PSA-selective oncolytic AD5 vector in a phase I trial in locally recurrent prostate cancer following radiation therapy","volume":"1","author":"Simons","year":"2000","journal-title":"Mol. Ther."},{"key":"10.1016\/S1040-8428(01)00103-2_BIB122","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1126\/science.286.5448.2244","article-title":"Clinical trials: gene therapy death prompts review of adenovirus vector","volume":"286","author":"Marshall","year":"1999","journal-title":"Science"},{"issue":"10","key":"10.1016\/S1040-8428(01)00103-2_BIB123","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1089\/10430349950017725","article-title":"A novel tumor-specific replication-restricted adenoviral vector for gene therapy of hepatocellular carcinoma","volume":"10","author":"Hallenbeck","year":"1999","journal-title":"Hum. Gene Ther."},{"issue":"6","key":"10.1016\/S1040-8428(01)00103-2_BIB124","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1172\/JCI9180","article-title":"Selectivity of a replication-competent adenovirus for human breast carcinoma cells expressing the MUC1 antigen","volume":"106","author":"Kurihara","year":"2000","journal-title":"J. Clin. Invest."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842801001032?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842801001032?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T01:46:17Z","timestamp":1578879977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842801001032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,6]]},"references-count":124,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2001,6]]}},"alternative-id":["S1040842801001032"],"URL":"https:\/\/doi.org\/10.1016\/s1040-8428(01)00103-2","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2001,6]]}}}